203 related articles for article (PubMed ID: 36172817)
21. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients.
Guerin J; Casey E; Feighery C; Jackson J
Autoimmunity; 1999 Oct; 31(2):109-16. PubMed ID: 10680749
[TBL] [Abstract][Full Text] [Related]
22. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
23. Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies.
Capozzi A; Manganelli V; Riitano G; Recalchi S; Truglia S; Alessandri C; Longo A; Garofalo T; Misasi R; Valesini G; Conti F; Sorice M
Clin Exp Immunol; 2019 Apr; 196(1):59-66. PubMed ID: 30549270
[TBL] [Abstract][Full Text] [Related]
24. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
25. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
26. Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events.
Ghebouli R; Loyau S; Maire M; Saboural P; Collet JP; Jandrot-Perrus M; Letourneur D; Chaubet F; Michel JB
Thromb Haemost; 2018 Jan; 118(1):42-53. PubMed ID: 29304524
[TBL] [Abstract][Full Text] [Related]
27. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
28. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons.
Runge MS; Harker LA; Bode C; Ruef J; Kelly AB; Marzec UM; Allen E; Caban R; Shaw SY; Haber E; Hanson SR
Circulation; 1996 Sep; 94(6):1412-22. PubMed ID: 8823001
[TBL] [Abstract][Full Text] [Related]
29. Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study.
Zengin E; Sarper N; Yazal Erdem A; Odaman Al I; Sezgin Evim M; Yaralı N; Belen B; Akçay A; Türedi Yıldırım A; Karapınar TH; Güneş AM; Aylan Gelen S; Ören H; Olcay L; Baytan B; Gülen H; Öztürk G; Orhan MF; Oymak Y; Akpınar S; Tüfekçi Ö; Albayrak M; Tatlı Güneş B; Canpolat A; Özbek N
Turk J Haematol; 2021 Dec; 38(4):294-305. PubMed ID: 34431642
[TBL] [Abstract][Full Text] [Related]
30. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
31. A Synergistic and Efficient Thrombolytic Nanoplatform: A Mechanical Method of Blasting Combined with Thrombolytic Drugs.
Hu L; Xu J; Zhang W; Wang J; Fang N; Luo Y; Xu L; Liu J; Zhang Y; Ran H; Guo D; Zhou J
Int J Nanomedicine; 2022; 17():5229-5246. PubMed ID: 36388875
[TBL] [Abstract][Full Text] [Related]
32. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.
Ma YH; Wu SY; Wu T; Chang YJ; Hua MY; Chen JP
Biomaterials; 2009 Jul; 30(19):3343-51. PubMed ID: 19299010
[TBL] [Abstract][Full Text] [Related]
33. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
Front Immunol; 2019; 10():460. PubMed ID: 30923525
[TBL] [Abstract][Full Text] [Related]
34. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
35. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
[TBL] [Abstract][Full Text] [Related]
36. Activation of Platelet mTORC2/Akt Pathway by Anti-β2GP1 Antibody Promotes Thrombosis in Antiphospholipid Syndrome.
Tang Z; Shi H; Chen C; Teng J; Dai J; Ouyang X; Liu H; Hu Q; Cheng X; Ye J; Su Y; Sun Y; Pan H; Wang X; Liu J; Su B; Yang C; Xu Y; Liu T
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1818-1832. PubMed ID: 37381985
[TBL] [Abstract][Full Text] [Related]
37. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
[TBL] [Abstract][Full Text] [Related]
38. Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis.
Ieko M; Ichikawa K; Atsumi T; Takeuchi R; Sawada KI; Yasukouchi T; Koike T
Semin Thromb Hemost; 2000; 26(1):85-90. PubMed ID: 10805287
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
[TBL] [Abstract][Full Text] [Related]
40. A novel platelet-rich arterial thrombosis model in rabbits. Simple, reproducible, and dynamic real-time measurement by using double-opposing inverted-sutures model.
Shieh SJ; Chiu HY; Shi GY; Wu CM; Wang JC; Chen CH; Wu HL
Thromb Res; 2001 Sep; 103(5):363-76. PubMed ID: 11553369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
